65,437 trials
Patellofemoral Pain Syndrome
Primary: Assessment of Change in Pain and Function Before and After Treatment With Kujala´s Test: Presented as Percentages and 95% Confidence Interval. — 20; 20; 20; 40…
COVID-19
Primary: Total Number of Serious Adverse Events (SAE) Through Study Day 14 — 0; 0 Serious Adverse Events
Weight Loss · Diet Modification · Physical Activity
Primary: Recruitment — 163; 105; 195; 65 Participants
Cocaine Dependence
Primary: Change in Interaction of the Serotonin Receptor (5-HTR) Type-2C Cys23Ser Single Nucleotide Polymorphism (SNP) and a 5-HT2AR Antagonist on the Functional Circuitry…
Mild Cognitive Impairment
Primary: Change in Readiness to Engage in ACP (ACP Engagement Scale) — 1.92; 1.54; 2.77; 2.00 units on a scale
Advanced Solid Tumors
Primary: Overall Response Rate (ORR) — 5.6; 0.0; 11.3; 14.3 percentage of participants
Uncomplicated Plasmodium Falciparum Malaria
Primary: Percentage of Patients With PCR-corrected Adequate Clinical and Parasitological Response (ACPR) on Day 28 — 11; 13; 15; 14 Participants
Diabetic Foot Ulcer · Surgical Wound
Primary: Number of Participants That Achieve Complete Wound Closure During the Twelve Week Study and the Percentage Change in Participant Ulcer Size at 12 Weeks From Baseline…
Metastatic Melanoma
Primary: Change in Immune-related Overall Response Rate (irORR) — 20 participants
Idiopathic Angioedema
Primary: Mean 7-day Angioedema Activity Score (AAS7) — 2.8; 1.6; 0.69; 0.20 score on a scale
Activity, Motor · Social Isolation
Primary: Change in Mean Daily Steps Walked From Baseline Period (Week 1) to Intervention Period (Weeks 2 and 3) — 483.95; 283.77 steps per day
Hearing Loss
Primary: Hearing Performance of Speech in Noise for Unaided Hearing and the Baha 6 Max Assessed Via Adaptive Speech Test in Noise — -3.7; 4.8 db SNR (decibel Speech in Noise Ratio)
Astigmatism · Myopia
Primary: Vision Stability While Doing Tasks on Mobile Phone — 88.37; 85.30 units on a scale
Caries
Primary: Caries Arrest of Teeth in the SDF Group Measured by Change in Size — 10 Participants
Malaria
Primary: Percentage of Participants With PCR-Corrected ACPR on Day 28 — 97.6; 98.8 percentage of cured subjects — p=<0.0001